Ad26.RSV.PreF-based Vaccine

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Respiratory Syncytial Virus Prevention

Drug Information

Target Indication

Respiratory Syncytial Virus Prevention

Clinical Trial

Last updated: 5/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

JNJ

Johnson & Johnson

Related Pipeline

Alzheimer's Disease

Post-operative Dental Pain

Osteoarthritis

Low Back Pain

Pneumonia

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts